Litican 50 mg/2 ml inj. sol. i.m./i.v. amp.

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Alizapride Hydrochloride 55,8 mg/2 ml - Eq. Alizapride 50 mg/2 ml

MAH:

Sanofi Belgium SA-NV

ATC_code:

A03FA05

INN:

Alizapride Hydrochloride

dosage:

50 mg/2 ml

pharmaceutical_form:

Solution for injection

composition:

Alizapride Hydrochloride

administration_route:

Intramuscular use; Intravenous use

therapeutic_area:

Alizapride

leaflet_short:

CTI code: 122823-01 - Pack size: 6 x 2 ml - Commercialisation status: YES - FMD code: 03582910086925 - CNK code: 0818724 - Delivery mode: Medical prescription

authorization_status:

Commercialised: Yes

authorization_date:

1983-04-27